Inflammatory Bowel Panel

Inflammatory Bowel Panel

Why It Matters

The Inflammatory Bowel Panel helps evaluate immune responses associated with gastrointestinal disorders, including celiac disease. By measuring specific antibodies, this panel provides information that may help identify gluten-related autoimmune activity and distinguish celiac disease from other conditions with overlapping digestive symptoms.

Who Should Get It

Recommended for patients experiencing chronic diarrhea, abdominal pain, bloating, unexplained weight loss, fatigue, or nutrient deficiencies. It may also benefit individuals with a family history of celiac disease or those requiring further evaluation for suspected gluten-related autoimmune disorders.

How This Panel Is Used

Physicians use this panel to investigate suspected celiac disease and evaluate immune responses to gluten. Results are interpreted alongside clinical history, other laboratory findings, and, when appropriate, additional diagnostic procedures to support accurate diagnosis and treatment planning.

What’s Included

This panel includes four antibody tests that measure IgA and IgG responses to deamidated gliadin peptides (DGP) and tissue transglutaminase (tTG). Together, these markers help evaluate suspected celiac disease and provide insight into gluten-related autoimmune activity.

Deamidated Gliadin Peptide (DGP) IgA

This test measures IgA antibodies against deamidated gliadin peptides (DGP), which are associated with an immune response to gluten.

Diagnostic Value: DGP IgA testing helps evaluate suspected celiac disease, particularly when used alongside other celiac-specific antibody tests.

Clinical Significance: Elevated DGP IgA levels may indicate an autoimmune response associated with celiac disease. Results should be interpreted alongside other serological findings and clinical history.

Symptom Correlation: DGP IgA testing may help investigate symptoms such as chronic diarrhea, abdominal pain, bloating, unexplained weight loss, and nutrient deficiencies.

The Gliadin DP IgA test provides additional information to support the evaluation of suspected celiac disease.

Deamidated Gliadin Peptide (DGP) IgG

This test measures IgG antibodies against deamidated gliadin peptides (DGP), which are associated with an immune response to gluten.

Diagnostic Value: DGP IgG testing helps evaluate suspected celiac disease, particularly in patients with IgA deficiency or when used alongside other celiac-specific antibody tests.

Clinical Significance: Elevated DGP IgG levels may indicate an immune response associated with celiac disease. Results should be interpreted alongside other serological findings and clinical history.

Symptom Correlation: DGP IgG testing may help investigate symptoms such as chronic diarrhea, abdominal pain, bloating, unexplained weight loss, and nutrient deficiencies.

The Gliadin DP IgG test provides additional information to support the evaluation of suspected celiac disease.

Tissue Transglutaminase (tTG) Antibodies, IgA

This test measures IgA antibodies against tissue transglutaminase (tTG), an enzyme involved in tissue repair. These antibodies are commonly associated with celiac disease.

Diagnostic Value: tTG IgA testing is a primary screening test for celiac disease, helping identify an autoimmune response triggered by gluten consumption.

Clinical Significance: Elevated tTG IgA levels strongly suggest celiac disease, although additional testing may be needed to confirm the diagnosis. Total IgA testing is often performed alongside tTG IgA to identify IgA deficiency, which can affect test accuracy.

Symptom Correlation: tTG IgA testing may help investigate symptoms such as chronic diarrhea, abdominal pain, bloating, unexplained weight loss, fatigue, and nutrient deficiencies.

The Tissue Transglutaminase (tTG) Antibodies IgA test provides important information for screening and evaluating suspected celiac disease.

Tissue Transglutaminase (tTG) Antibodies, IgG

This test measures IgG antibodies against tissue transglutaminase (tTG), an enzyme involved in tissue repair. These antibodies may be associated with an autoimmune response to gluten in individuals with celiac disease.

Diagnostic Value: tTG IgG testing helps evaluate suspected celiac disease, particularly in patients with IgA deficiency, where IgA-based antibody tests may be less reliable.

Clinical Significance: Elevated tTG IgG levels may support a diagnosis of celiac disease, especially in individuals with confirmed IgA deficiency. Results should be interpreted alongside other serological findings, total IgA levels, and clinical history.

Symptom Correlation: tTG IgG testing may help investigate symptoms such as chronic diarrhea, abdominal pain, bloating, unexplained weight loss, fatigue, and nutrient deficiencies.

The Tissue Transglutaminase (tTG) Antibodies IgG test provides additional information to support the evaluation of suspected celiac disease.

This panel includes IgA and IgG antibodies against deamidated gliadin peptides (DGP) and tissue transglutaminase (tTG), providing valuable information for evaluating gluten-related autoimmune responses and supporting the diagnosis of celiac disease.